ライブラリ登録: Guest
Critical Reviews™ in Therapeutic Drug Carrier Systems

年間 6 号発行

ISSN 印刷: 0743-4863

ISSN オンライン: 2162-660X

The Impact Factor measures the average number of citations received in a particular year by papers published in the journal during the two preceding years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) IF: 2.7 To calculate the five year Impact Factor, citations are counted in 2017 to the previous five years and divided by the source items published in the previous five years. 2017 Journal Citation Reports (Clarivate Analytics, 2018) 5-Year IF: 3.6 The Immediacy Index is the average number of times an article is cited in the year it is published. The journal Immediacy Index indicates how quickly articles in a journal are cited. Immediacy Index: 0.8 The Eigenfactor score, developed by Jevin West and Carl Bergstrom at the University of Washington, is a rating of the total importance of a scientific journal. Journals are rated according to the number of incoming citations, with citations from highly ranked journals weighted to make a larger contribution to the eigenfactor than those from poorly ranked journals. Eigenfactor: 0.00023 The Journal Citation Indicator (JCI) is a single measurement of the field-normalized citation impact of journals in the Web of Science Core Collection across disciplines. The key words here are that the metric is normalized and cross-disciplinary. JCI: 0.39 SJR: 0.42 SNIP: 0.89 CiteScore™:: 5.5 H-Index: 79

Indexed in

Transcutaneous Immunization: An Emerging Route of Immunization and Potent Immunostimulation Strategy

巻 18, 発行 5, 2001, 24 pages
DOI: 10.1615/CritRevTherDrugCarrierSyst.v18.i5.30
Get accessGet access

要約

Transcutaneous immunization (TCI) has emerged recently as a new method of vaccination that uses the skin. The simplicity of a patch-based immunization may obscure the potency of this strategy for immunostimulation because TCI allows the safe use of a wide variety of potent adjuvants. It is thought that these adjuvants activate Langerhans cells in the skin, which migrate to the draining lymph to orchestrate robust systemic immune responses. TCI represents a novel combination using established knowledge relating to skin penetration, the potency of adjuvant-based immunostimulation, and data showing that Langerhans cells are highly desirable targets because of their antigen-presenting cell function. The near-term challenge will be to take this promising insight into successful product development.

によって引用された
  1. Kenney Richard T., Glenn Gregory M., Transcutaneous immunization using the heat-labile enterotoxin of E. coli as an adjuvant, in Immunopotentiators in Modern Vaccines, 2006. Crossref

  2. Plotkin Stanley A., Six Revolutions in Vaccinology, Pediatric Infectious Disease Journal, 24, 1, 2005. Crossref

  3. Li Ni, Peng Li-Hua, Chen Xi, Nakagawa Shinsaku, Gao Jian-Qing, Transcutaneous vaccines: Novel advances in technology and delivery for overcoming the barriers, Vaccine, 29, 37, 2011. Crossref

  4. Li Ni, Peng Li-Hua, Chen Xi, Zhang Tian-Yuan, Shao Guo-Feng, Liang Wen-Quan, Gao Jian-Qing, Antigen-loaded nanocarriers enhance the migration of stimulated Langerhans cells to draining lymph nodes and induce effective transcutaneous immunization, Nanomedicine: Nanotechnology, Biology and Medicine, 10, 1, 2014. Crossref

  5. Azagury Aharon, Khoury Luai, Enden Giora, Kost Joseph, Ultrasound mediated transdermal drug delivery, Advanced Drug Delivery Reviews, 72, 2014. Crossref

  6. Partidos Charalambos D., New Approaches to Vaccine Delivery, in Topley & Wilson's Microbiology and Microbial Infections, 2010. Crossref

  7. Nataro James P., Levine Myron M., New Vaccine Technologies, in Topley & Wilson's Microbiology and Microbial Infections, 2010. Crossref

  8. Hoelscher Mary, Gangappa Shivaprakash, Zhong Weimin, Jayashankar Lakshmi, Sambhara Suryaprakash, Vaccines against epidemic and pandemic influenza, Expert Opinion on Drug Delivery, 5, 10, 2008. Crossref

  9. Karande Pankaj, Arora Anubhav, Pham Thien Kahn, Stevens Daniel, Wojicki Arthur, Mitragotri Samir, Transcutaneous immunization using common chemicals, Journal of Controlled Release, 138, 2, 2009. Crossref

  10. Wilson Rebecca L., Hruby Dennis E., Commensal bacteria as a novel delivery system for subunit vaccines directed against agents of bioterrorism, Advanced Drug Delivery Reviews, 57, 9, 2005. Crossref

  11. Glenn Gregory M, Kenney Richard T, Hammond Scott A, Ellingsworth Larry R, Transcutaneous immunization and immunostimulant strategies, Immunology and Allergy Clinics of North America, 23, 4, 2003. Crossref

  12. Gupta Prem N., Mishra Vivek, Rawat Amit, Dubey Praveen, Mahor Sunil, Jain Sanyog, Chatterji D.P., Vyas Suresh P., Non-invasive vaccine delivery in transfersomes, niosomes and liposomes: a comparative study, International Journal of Pharmaceutics, 293, 1-2, 2005. Crossref

  13. Hirschberg Hoang J.H.B., van Riet Elly, Oosterhoff Dinja, Bouwstra Joke A., Kersten Gideon F.A., Animal models for cutaneous vaccine delivery, European Journal of Pharmaceutical Sciences, 71, 2015. Crossref

  14. Lambert Paul Henri, Laurent Philippe E., Intradermal vaccine delivery: Will new delivery systems transform vaccine administration?, Vaccine, 26, 26, 2008. Crossref

  15. Tyagi Rajeev K., Garg Neeraj K., Jadon Rajesh, Sahu Tejram, Katare Om Prakash, Dalai Sarat K., Awasthi Amit, Marepally Srujan K., Elastic liposome-mediated transdermal immunization enhanced the immunogenicity of P. falciparum surface antigen, MSP-119, Vaccine, 33, 36, 2015. Crossref

  16. Song Jae-Min, Kim Yeu-Chun, Barlow Peter G., Hossain M. Jaber, Park Kyoung-Mi, Donis Ruben O., Prausnitz Mark R., Compans Richard W., Kang Sang-Moo, Improved protection against avian influenza H5N1 virus by a single vaccination with virus-like particles in skin using microneedles, Antiviral Research, 88, 2, 2010. Crossref

  17. Naito Seishiro, Maeyama Jun-ichi, Mizukami Takuo, Takahashi Motohide, Hamaguchi Isao, Yamaguchi Kazunari, Transcutaneous immunization by merely prolonging the duration of antigen presence on the skin of mice induces a potent antigen-specific antibody response even in the absence of an adjuvant, Vaccine, 25, 52, 2007. Crossref

  18. Zurbriggen Rinaldo, Metcalfe Ian C, Glück Reinhard, Viret Jean-François, Moser Christian, Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine, Expert Review of Vaccines, 2, 2, 2003. Crossref

  19. Partidos Charalambos D., Beignon Anne-Sophie, Briand Jean-Paul, Muller Sylviane, Modulation of immune responses with transcutaneously deliverable adjuvants, Vaccine, 22, 19, 2004. Crossref

  20. Tyagi Rajeev K., Garg Neeraj K., Dalai Sarat K., Awasthi Amit, Transdermal immunization ofP. falciparumsurface antigen (MSP-119) via elastic liposomes confers robust immunogenicity, Human Vaccines & Immunotherapeutics, 12, 4, 2016. Crossref

  21. Jia Yimei, McCluskie Michael J., Zhang Dongling, Monette Robert, Iqbal Umar, Moreno Maria, Sauvageau Janelle, Williams Dean, Deschatelets Lise, Jakubek Zygmunt J., Krishnan Lakshmi, In vitro evaluation of archaeosome vehicles for transdermal vaccine delivery, Journal of Liposome Research, 28, 4, 2018. Crossref

  22. CHEN Dexiang, PAYNE Lendon G, Targeting epidermal Langerhans cells by epidermal powder immunization, Cell Research, 12, 2, 2002. Crossref

  23. Hein Wayne R., Griebel Philip J., A road less travelled: large animal models in immunological research, Nature Reviews Immunology, 3, 1, 2003. Crossref

  24. Glenn G. M., Kenney R. T., Mass Vaccination: Solutions in the Skin, in Mass Vaccination: Global Aspects — Progress and Obstacles, 304, 2006. Crossref

  25. Sonzogni Ana S., Yealland Guy, Kar Mrityunjoy, Wedepohl Stefanie, Gugliotta Luis M., Gonzalez Verónica D. G., Hedtrich Sarah, Calderón Marcelo, Minari Roque J., Effect of Delivery Platforms Structure on the Epidermal Antigen Transport for Topical Vaccination, Biomacromolecules, 19, 12, 2018. Crossref

  26. Arora Anubhav, Hakim Itzhak, Baxter Joy, Rathnasingham Ruben, Srinivasan Ravi, Fletcher Daniel A., Mitragotri Samir, Needle-free delivery of macromolecules across the skin by nanoliter-volume pulsed microjets, Proceedings of the National Academy of Sciences, 104, 11, 2007. Crossref

  27. Andreakos E., Williams R. O., Wales J., Foxwell B. M., Feldmann M., Activation of NF-κB by the intracellular expression of NF-κB-inducing kinase acts as a powerful vaccine adjuvant, Proceedings of the National Academy of Sciences, 103, 39, 2006. Crossref

  28. Song Xinran, Jiang Yuxin, Zhang Weixing, Elfawal Gomaa, Wang Kaili, Jiang Di, Hong Huoyan, Wu Jinglei, He Chuanglong, Mo Xiumei, Wang Hongsheng, Transcutaneous tumor vaccination combined with anti-programmed death-1 monoclonal antibody treatment produces a synergistic antitumor effect, Acta Biomaterialia, 140, 2022. Crossref

Begell Digital Portal Begellデジタルライブラリー 電子書籍 ジャーナル 参考文献と会報 リサーチ集 価格及び購読のポリシー Begell House 連絡先 Language English 中文 Русский Português German French Spain